Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Drug Device Combination Products

Explore the unique challenges of combination products and the EU MDR

2018 Highlights Include:

Keep up to date...
  • What are the best strategies for implementing the EU MDR for combination products?
  • FDA latest regulatory updates and requirements
  • Pre-filled syringes: design to distribution
  • Implementing human factors testing and "user centric designs"
  • Overcoming the difficulties of packaging and labelling for combination products
Competent Authorities and Notified Body perspectives from:
  • FDA
  • SQS
  • UL
Get involved...
  • Meet key Notified Bodies working with drug device combination products
  • Get stuck in with interactive guidance on performing market usability testing

Free On-Demand Content

Webinars. Webinars. Webinars.

Latest status and practical experience of implementing the new EU MDR

Bassil Akra, Vice President, Global Focus Teams (Cardiovascular, Orthopeadic and Clinical), TÜV SÜD Product Service GmbH, Germany